Impact of Cytomegalovirus Viral Load on Probability of Spontaneous Clearance and Response to Preemptive Therapy in Allogeneic Stem Cell Transplantation Recipients
José F. Camargo(University of Miami), Krishna V. Komanduri(University of Miami), Antonio Jiménez(University of Miami), Erik L. Kimble(University of Washington), Denise Pereira(Neurology Center of Southern California), Amer Beitinjaneh(University of Miami), Mark Goodman(University of Miami), Lilian M. Abbo, Jacques Simkins(University of Miami), Rossana Rosa(Jackson Memorial Hospital), John Byrnes(SRI International), Lazaros J. Lekakis(University of Miami Hospital), Maria X. Bueno(Jackson Memorial Hospital), Luis Shimose(Jackson Memorial Hospital), Eric Wieder(University of Miami), Nikeshan Jeyakumar(Stanford Blood Center), Cara L. Benjamin, Michele I. Morris(University of Miami), Maritza C. Alencar(University of Miami)
Cited by 72
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
|Clinical Infectious Diseases|2016|3k
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1–2 trial
|The Lancet Oncology|2018|2.3k
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k